Press Release Archives - NFCR

Press Release

DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083’s Participation in a Pivotal Study for Glioblastoma Sponsored by the Global Coalition for Adaptive Research

SAN DIEGO, June 24, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today it has received a $500,000 loan from the National Brain Tumor Society (NBTS) and the National Foundation for Cancer…...

Read more

First-in-Class Drug Candidate Developed Through National Foundation for Cancer Research Funding Commences International Phase IIB Liver Cancer Clinical Trial

FOR IMMEDIATE RELEASE: May 19, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Three Decades of NFCR Basic and Translational Research Funding to Primary Investigator Dr. Yung-Chi Cheng and Project Advances New Systems Biology Paradigm for Cancer Treatment…...

Read more

NFCR Takes Steps to Address Cancer Community Needs During Coronavirus Pandemic

FOR IMMEDIATE RELEASE: April 14, 2020                                                  CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD –The National Foundation for Cancer Research (NFCR) has launched an online resource center targeted especially to cancer patients and caregivers during the COVID-19…...

Read more

NFCR-Backed Technology Receives FDA’s Assent for Lymphoma Clinical Trials

FOR IMMEDIATE RELEASE: March 12, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – A drug and drug delivery candidate technology, research into which has been funded by the National Foundation for Cancer Research (NFCR), has…...

Read more

Michael Hall Named 2020 Sjöberg Prize Recipient

Michael N. Hall, Ph.D., the National Foundation for Cancer Research’s (NFCR) 2017 Szent-Györgyi Prize for Progress in Cancer Research winner, and David Sabatini, M.D., Ph.D., were named winners of the 2020 Sjöberg Prize “for their discovery of the target of rapamycin and the mammalian target of rapamycin, and their roles…...

Read more

2020 Szent-Gyorgyi Prize Awarded to a Pioneering Researcher Who Has Unlocked Workings of Cancer Drugs of Natural Product Origin

FOR IMMEDIATE RELEASE: February 13, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – The National Foundation for Cancer Research (NFCR) announced today that Susan Band Horwitz, Ph.D., has been selected to receive the 2020 Szent-Györgyi…...

Read more

NFCR Funded Translational Cancer Research Project Receives Virginia Catalyst Grant

FOR IMMEDIATE RELEASE: December 23, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – A translational research project supported by the National Foundation for Cancer Research (NFCR) has been awarded $700,000 from Virginia Catalyst to advance…...

Read more

National Foundation for Cancer Research Conducts Salisbury Award Competition

FOR IMMEDIATE RELEASE: November 19, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Winner and Runners-Up Named, Salisbury Family Honored ROCKVILLE, MD – The National Foundation for Cancer Research (NFCR) last Thursday, November 14, conducted its latest Salisbury Award…...

Read more

NFCR Fellow Susan Band Horwitz Named Giant of Cancer Care

 FOR IMMEDIATE RELEASE: June 3, 2019   CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Management E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Becomes the Fifth National Foundation for Cancer Research Scientist to Receive the Honor ROCKVILLE, MD – National Foundation for Cancer Research (NFCR) Fellow Susan…...

Read more

NFCR Fellow Susan Band Horwitz Receives Canada Gairdner Award

FOR IMMEDIATE RELEASE: April 2, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Canada’s Most Prominent Scientific Prize Honors World’s Biomedical Research Elite ROCKVILLE, MD – Susan Band Horwitz, Ph.D., has today been named one of seven…...

Read more